Company News in the Life Science Industry

»

Reset 

Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Corvus Pharmaceuticals, Inc.

Nasus Pharma Announces Data Demonstrating Efficacy of TaffiX® Intranasal Antiviral Protection Against SARS-CoV-2

Read more ››
By: GlobenewsWire - 07 Jul 2020

DLT Resolution Successfully Deployed Its Vote YourChoice™ Secure Online & Remote Voting Application for Manufacturing Union Election

Read more ››
By: GlobenewsWire - 07 Jul 2020

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Apellis Pharmaceuticals, Inc.

Cybrexa Therapeutics Completes Successful Pre-IND Meeting With FDA for CBX-12 (alphalex™-exatecan), a Novel Treatment for Solid Tumors

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Cybrexa Therapeutics

BioXcel Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering Formulation for BXCL501 and Methods of Treating Agitation

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  BioXcel Therapeutics, Inc.

Major Shareholder Announcement

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Genmab A/S

Myriad Announces New Studies Validating the Ability of Myriad’s riskScore® Test to Modify Breast Cancer Risk Prediction

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Myriad Genetics, Inc.

Theratechnologies Confirms Bioequivalence of New Tesamorelin Formulation

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Theratechnologies Inc.

Strongbridge Biopharma plc Announces Appointment of John H. Johnson to Chief Executive Officer

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Strongbridge Biopharma plc

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement For Repotrectinib in Greater China

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Turning Point Therapeutics, Inc.

Jushi Holdings Inc. Reports First Quarter 2020 Financial Results

Read more ››
By: GlobenewsWire - 07 Jul 2020

Vaccinex Provides Update of Potentially Pivotal SIGNAL Clinical Trial in Huntington’s Disease

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Vaccinex, Inc

ORYZON Raises its Share Capital by EUR 20 Million

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Oryzon Genomics, S.A.

In Vitro Testing of Innovation Pharmaceuticals’ Brilacidin for COVID-19 Shows Consistent Anti-SARS-CoV-2 Efficacy; Manufacturing Preparation Underway for COVID-19 Clinical Trial

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Innovation Pharmaceuticals Inc.

Algernon Begins Screening Patients for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Algernon Pharmaceuticals Inc.

Immune Therapeutics, Inc. Provides Shareholder Update

Read more ››
By: GlobenewsWire - 07 Jul 2020

Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Cabaletta Bio, Inc.

IntelGenx and Cybin Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  IntelGenx Corp.

Protech Home Medical Provides Corporate Update as Company Positioned to Accelerate Growth

Read more ››
By: GlobenewsWire - 07 Jul 2020
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies